1. Molnupiravir Is Next
In the next five weeks or so, kids 5 and over will be able to get a vaccine for COVID.
Today we have news that Merck’s antiviral pill, Molnupiravir, is moving forward to seek approval from the FDA.
Initial studies suggest that Molnupiravir—Worst. Branding. Ever.—will reduce hospitalizations and deaths among symptomatic…
Keep reading with a 7-day free trial
Subscribe to The Bulwark to keep reading this post and get 7 days of free access to the full post archives.